Delivery Order SPE2DB20D1100-SPE2DB25FA9W2

Award Date 3/6/25
Potential Completion Date 3/7/25
Potential Value $2.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,097.08 delivery order contract is for the supply of the drug Wegovy (0.5 mg/0.5 ml pen, 0.5 ml) to support federal healthcare programs. The contract has a firm fixed price pricing type and an ultimate completion date of April 9, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $16,390.81, is for the delivery of the drug Wegovy 2.4 mg/0.75 ml pen in 0.75 ml quantities. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $132,438.07, is for the delivery of the medication Wegovy 0.5 mg/0.5 ml pen with an ultimate completion date of May 30, 2024. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract...
This federal contract award, valued at $11,466.00, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for Wegovy 0.5 mg/0.5 ml pens, with a completion date of December 17, 2024. The contract is a firm fixed-price arrangement, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,180.41, is for the delivery of the drug Wegovy 1.7 mg/0.75 ml pen 0.75 ml. The contract is a firm fixed-price delivery order with a completion date of December 14, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) the company holds with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, with a ceiling value of $1,228.50, is for the delivery of Wegovy 2.4 mg/0.75 ml pen 0.75 ml, a prescription medication. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,641.60 Firm Fixed Price delivery order contract is for the supply of the medication Wegovy 0.25 mg/0.5 ml pen with an ultimate completion date of November 22, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,572.66, is for the delivery of Wegovy 1 mg/0.5 mL pens. It is a firm-fixed-price delivery order contract with a completion date of January 30, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,817.64, is for the delivery of the drug Wegovy 1.7 mg/0.75 ml pen 0.75ml. This is a Firm Fixed Price delivery order contract with a period of performance ending on March 3, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $7,916.40, is for the delivery of the medication Wegovy in a 0.5 mg/0.5 ml pen form. This is a Firm Fixed Price Delivery Order contract with an ultimate completion date of October 29, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FA9W2
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,866.50, is for the delivery of the medication Wegovy 0.5 mg/0.5 ml pen 0.5 ml. It is a firm fixed-price delivery order contract with a period of performance through March 7, 2025.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 6/5/25, 9:49 AM